Morgan Stanley Capital Partners Acquires FoodScience

NEW YORK & WILLISTON, Vt.--(BUSINESS WIRE)-- Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), the middle-market focused private equity team at Morgan Stanley Investment Management, have acquired FoodScience, a vertically integrated provider of pet and human nutritional supplements, from Wind Point Partners. Sharon Rossi will continue as FoodScience’s Chief Executive Officer.

Headquartered in Williston, Vermont, FoodScience drives a science-first approach to formulate, manufacture, market, and distribute nutritional supplements for pets and humans. FoodScience offers a broad portfolio of nutritional supplements through VetriScience®, DaVinci®, and Pet Naturals® brands, as well as private label and custom formulation offerings.

Commenting on the acquisition, James Stewart, Managing Director and Co-Head of Consumer Investing at MSCP, said: “We were drawn to FoodScience’s more than 50-year history, stellar reputation and mission to help people and pets live healthier lives. Under Sharon’s leadership, they have built a leading platform dedicated to delivering safe, effective, and innovative brands while serving as the partner of choice to FoodScience’s contract manufacturing customers. We look forward to working together as we collectively seek to build on and expand the exceptional product portfolio through continued organic growth and M&A.”

“MSCP’s investment serves as a further testament to FoodScience’s legacy and mission-driven culture,” said Ms. Rossi. “We are excited to partner with the MSCP team and look forward to leveraging their network and expertise in the pet and animal health sector to accelerate our growth both organically and through strategic acquisitions.”

MSCP’s acquisition of FoodScience represents its third investment in the Pet and Animal Health sector, following the successful 2020 exits of Compana Pet Brands (formerly known as Manna Pro) and Thrive Pet Healthcare (formerly known as Pathway Vet Alliance).

Jones Day acted as legal counsel and William Blair acted as exclusive financial advisor to MSCP.

About FoodScience
FoodScience is a leading provider of pet and human supplements with in-house manufacturing capabilities. Through its VetriScience and Pet Naturals brands, the Company offers a range of supplements for dogs and cats focused on joint health, behavioral, digestive, and more. The Company’s human brand, DaVinci, offers supplements for general health, heart, hormone, digestive, immune, and more. For more information, please visit the Company’s website www.foodsciencecorp.com.

About Morgan Stanley Capital Partners
Morgan Stanley Capital Partners, part of Morgan Stanley Investment Management, is a leading middle-market private equity platform established in 1986 that focuses on privately negotiated equity and equity-related investments primarily in North America. Morgan Stanley Capital Partners seeks to create value in portfolio companies primarily in a series of subsectors in the business and consumer, healthcare, and industrial services markets with an emphasis on driving significant organic and acquisition growth through an operationally focused approach. For further information about Morgan Stanley Capital Partners, please visit www.morganstanley.com/im/capitalpartners.

About Morgan Stanley Investment Management
Morgan Stanley Investment Management, together with its investment advisory affiliates, has more than 1,400 investment professionals around the world and $1.6 trillion in assets under management or supervision as of September 30, 2024. Morgan Stanley Investment Management strives to provide outstanding long-term investment performance, service, and a comprehensive suite of investment management solutions to a diverse client base, which includes governments, institutions, corporations and individuals worldwide. For further information about Morgan Stanley Investment Management, please visit www.morganstanley.com/im.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241118822513/en/

Press

Morgan Stanley: Alyson Barnes

alyson.barnes@morganstanley.com

Source: Morgan Stanley Capital Partners